Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-025061
Filing Date
2016-07-13
Accepted
2016-07-13 17:00:03
Documents
1
Period of Report
2016-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4461
  Complete submission text file 0000899243-16-025061.txt   6833
Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 161766037

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 87 MARY STREET GEORGE TOWN GRAND CAYMAN E9 KY1-9005 2127056229
QVT Fund V LP (Reporting) CIK: 0001543904 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 161766036

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations